Skip to main content
. 2022 May 27;40(7):1769–1775. doi: 10.1007/s00345-022-04036-w

Fig. 2.

Fig. 2

Change in IPSS-related quality of life (QoL) for all study visits (n = 83). IPSS-related QoL for all study visits according to the question “If you were to spend the rest of your life with your urinary condition the way it is now, how would you feel about that?” ( primary analysis set, n = 83; *missing values for two patients after 6 months. **Treatment was continued for up to 24 months in 55 patients (Fig. 1). Data are presented in Supplementary Table 1